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Clinical presentation and examination Women	with	PVD	present	themselves	with	complaints	of	burning,	stinging	or	tearing	pain	at	the	entrance,	which	can	be	provoked	upon,	during	and	following	penetration	in	the	vagina	and	by	touching	the	vestibulum	and	the	introitus	of	the	vagina.	This	can	be	caused,	for	example,	by	sexual	intercourse,	insertion	of	a	tampon	or	a	finger,	a	gynaecologic	examination,	wearing	tight	pants	or	sitting	on	a	saddle.	The	pain	can	be	localised	on	one	spot	but	is	mostly	affecting	different	spots	in	the	vestibulum.	Often,	there	is	no	pain	in	the	absence	of	touch,	as	the	definition	of	PVD	requires,	although	burning	pain	or	dull	background	pain	can	continue	after	penetration	or	touch	and	can	last	from	minutes	to	days.	Despite	the	pain,	most	women	tend	to	persist	in	having	sexual	intercourse.16,17	Women	may	describe	a	feeling	that	something	is	blocking	their	vagina	when	they	attempt	to	have	sexual	intercourse,	a	symptom	of	pelvic	floor	overactivity.	Examination	of	the	vulva	by	a	physician	will	show	a	normal	aspect	of	the	vulva	that	is	tender	around	the	vestibulum	and/or	introitus	after	slight	pressure	with	a	cotton	swab	or	finger.	Recently,	however,	a	study	showed	that	a	positive	cotton	swab	test	cannot	be	considered	equivalent	to	PVD	as	women	without	PVD	also	can	have	painful	vestibular	spots	on	touch.18	There	might	be	localised	erythema	at	the	spots	with	maximal	tenderness,	but	this	is	a	non-specific	finding.1		The	pelvic	floor	muscles	are	typically	tense	and	tender	and	most	women	are	not	aware	how	to	control	their	pelvic	floor	muscles.	To	date,	there	is	no	gold	standard	to	diagnose	pelvic	floor	overactivity.	Any	further	investigation	should	be	directed	at	confirming	or	excluding	other	pathologies,	such	as	chronic	or	recurrent	candidiasis,	painful	dermatoses,	or	rarely,	pudendal	neuralgia.	A	bimanual	vaginal	or	speculum	examination	is	very	seldomly	needed,	as	there	is	no	pathology	of	the	internal	genital	organs	that	could	explain	the	superficial	vulvar	complaints.	Sometimes	it	could	be	useful	as	the	absence	of	pathology	might	reassure	the	woman.	Because	an	examination	is	not	indicated	to	establish	the	diagnosis	of	PVD	but	is	mainly	helpful	in	excluding	other	pathologies,	taking	a	thorough	history	should	be	the	main	
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focus	in	diagnosing	PVD.	However,	women	present	their	complaints	typically	not	in	the	way	they	are	defined.	In	a	population-based	case-control	study	in	the	US	of	women	meeting	self	reported	vulvodynia	criteria,	it	was	found	that,	although	the	most	frequent	pain	descriptors	were	"irritating",	"burning",	and	"raw",	27.8%	also	described	the	pain	as	"itchy".7	These	women	needed	an	average	of	2.5	descriptors	to	describe	their	pain.7	Besides	that	a	patient	might	feel	burning	pain	as	irritation	or	itch,	normal	physiological	vaginal	discharge	might	be	described	as	smelling	or	disgusting	or	falsely	interpreted	as	infectious.	Also,	women	themselves	are	mostly	not	able	to	determine	the	correct	diagnosis	of	vulvovaginal	candidiasis	accurately,	thus	prompting	a	physician	not	only	to	focus	on	the	assumption	of	the	women.19	Moreover,	as	studies	show,	the	physician	needs	to	be	aware	of	the	shame,	low	self-esteem	and	negative	genital	self-image	of	women	with	PVD	presenting	their	complaints.20,21	Therefore,	complaints	might	be	presented	as	compelling	or	neglectful	or	embedded	in	other	non-gynaecological	complaints,	making	it	difficult	to	establish	the	real	request	or	need	for	help.		In	summary,	a	woman	with	PVD	will	present	herself	to	a	GP	with	some	reluctance	and	describe	her	provoked	vulvar	pain	in	non-specific	terms.	During	the	examination	of	the	vulva	the	GP	will	find	a	normally	looking	vulva	that	is	tender	around	the	vestibulum	on	slight	pressure	and	also	may	find	an	overactive	pelvic	floor.	In	order	to	support	the	diagnosis	and	to	understand	the	need	for	help,	the	GP	should	involve	the	context	of	PVD	in	the	diagnostic	process.		
The context of PVD A	complaint	or	clinical	syndrome	like	PVD	is	not	limited	to	an	isolated	pathophysiological	phenomenon,	and	therefore	its	cause,	dynamics	and	clinical	presentation	should	be	understood	in	relation	to	other	bio-psycho-social	factors	like	age,	ethnicity,	comorbidity,	sexuality	and	partner	responses.	These	factors	are	considered	briefly.	
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Table	1.	Symptoms	suggestive	of	PVD	in	relation	to	Pain	syndromes		 	 Muscle	pain		n=729	 General	weakness/tiredness	n=2697	 IBS		n=1188	Genital	pain	n=200	 Odds	 3.89**	 2.58*	 4.27**	CI	95%	 2.11-7.18	 1.70-3.90	 2.65-6.88	n	 11	 26	 19	Pretest	 0.02	 0.06	 0.02	Posttest	 0.06	 0.15	 0.10		 	 	 	 	Painful	intercourse	n=117	 Odds	 0.57	 3.13*	 2.57*	CI	95%	 0.08-4.08	 1.89-5.18	 1.19-5.53	n	 1	 18	 7	Pretest	 0.02	 0.06	 0.02	Posttest	 0.01	 0.18	 0.06		 	 	 	 	Other	symptoms/complaints	vagina	n=291	
Odds	 0.92	 1.83*	 4.01**	CI	95%	 0.34-2.48	 1.24-2.71	 2.67-6.03	n	 4	 28	 26	Pretest	 0.02	 0.06	 0.02	Posttest	 0.01	 0.11	 0.10		 	 	 	 	Other	symptoms/complaints	vulva	n=351	









Depressive	disorder		n=2012	Genital	pain	n=200	 Odds	 2.73*	 2.15*	 2.18*	CI	95%	 1.58-4.72	 1.27-3.65	 1.32-3.59	n	 14	 15	 17	Pretest	 0.03	 0.04	 0.04	Posttest	 0.08	 0.08	 0.09		 	 	 	 	Painful	intercourse	n=117	 Odds	 1.28	 2.75*	 2.19*	CI	95%	 0.47-3.47	 1.48-5.13	 1.14-4.19	n	 4	 11	 10	Pretest	 0.03	 0.04	 0.04	Posttest	 0.04	 0.10	 0.09		 	 	 	 	Other	symptoms/complaints	vagina	n=291	
Odds	 2.54*	 2.50*	 1.54	CI	95%	 1.59-4.06	 1.66-3.78	 0.96-2.49	n	 19	 25	 18	Pretest	 0.03	 0.04	 0.04	Posttest	 0.07	 0.09	 0.07		 	 	 	 	Other	symptoms/complaints	vulva	n=351	







Table	3.	Symptoms	suggestive	of	PVD	in	relation	to	Vulvovaginal	candidiasis			 	 Vulvovaginal	candidiasis	n=3230	Genital	pain	n=200	 Odds	 3.57**	CI	95%	 2.52-5.06	N	 40	Pretest	 0.07	Posttest	 0.25		 	 	Painful	intercourse	n=117	 Odds	 7.72***	CI	95%	 5.27-11.31	N	 41	Pretest	 0.07	Posttest	 0.54		 	 	Other	symptoms/complaints	vagina	n=291	
Odds	 4.56**	CI	95%	 3.48-5.98	N	 70	Pretest	 0.07	Posttest	 0.32		 	 	Other	symptoms/complaints	vulva	n=351	
Odds	 5.54**	CI	95%	 4.37-7.02	N	 97	Pretest	 0.07	Posttest	 0.38		
Note		 **			effect	size	large	(OR	≥	3.48	and	≤	6.71)		 ***	effect	size	very	large	(OR	≥	6.72)		
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VVC and uncertain VVC VVC	and	uncertain	VVC	were	defined	as	follows.	1. VVC	According	to	the	Dutch	Guideline	on	Vaginal	Discharge,	a	VVC	(ICPC	code	X72)	is	considered	very	likely,	when	the	patients	history	and	physical	exam	display	itching	and	non-smelling,	white	crumbling	discharge	in	combination	with	a	red	swollen	vulva	or	vaginal	wall.1	According	to	this	Guideline	a	physical	exam	can	be	omitted	if	the	patient	recognizes	the	complaints	from	an	earlier	episode	of	VVC.	In	case	of	doubt,	a	positive	yeast	culture	or	KOH	preparation	showing	hyphae	is	indicated	to	establish	a	definite	diagnosis.		2. Uncertain	VVC,	as	is	defined	by	us:	a) Recurrent	VVC	(RVVC):	when	a	patient	presents	with	3	or	more	episodes	of	VVC	within	a	year,	of	which	at	least	one	is	confirmed	by	the	GP	in	a	face-to-face	consultation.	The	frequent	recurrence	of	a	VVC	might	be	an	indication	that	in	one	way	or	another	the	policy	of	the	GP	was	insufficient.	To	prevent	missing	patients	with	RVVC	in	2014,	we	traced	patients	with	VVC	once	or	twice	in	2014,	back	to	2013.		b) Persisting	VVC	(PVVC):	when	a	patient	returns	for	a	second	consultation	within	one	episode	of	VVC,	suggesting	that	the	previous	consultation	was	insufficient.	Episodes,	used	in	the	NIVEL	Primary	Care	Database,	are	constructed	periods	for	a	specific	diagnosis.	Because	a	symptom-free	period	for	VVC	lasts	eight	weeks	before	a	new	episode	of	VVC	can	be	started,	a	complaint	was	considered	persistent	when	a	patient	had	consulted	the	GP	at	least	two	times	with	the	same	complaint	within	a	time	period	of	eight	weeks.				











Table	1.	Factors	associated	with	provoked	vulvodynia	for	vulvovaginal	candidiasis	(VVC)	and	uncertain	VVC	(in	%)			 VVC			(n=5,088)	 Uncertain	VVC	(n=1,978)	 P-value	
Female	genital	symptoms	 	 	 	 	Dyspareunia	 1.1	 2.1	 <0.001	 ***	Vaginal	symptom	/	complaint	other	 6.9	 10.3	 <0.001	 ***	Vulva	symptom	/	complaint	 2.3	 3.1	 0.019		 *	Vaginitis	/	vulvitis	NOS	 12.6	 16.9	 <0.001	 ***						 	 	 	 	
Medical	unexplained	
symptoms	
	 	 	 	Weakness	/	tiredness	in	general	 16.3	 19.4	 <0.001	 ***	Muscle	pain	 4.2	 4.8	 0.186	 	Irritable	bowel	syndrome	 5.3	 6.9	 0.001		 **		 	 	 	 	
Psychological	conditions	 	 	 	 	Feeling	anxious	/	nervous	/	tense	 5.3	 6.3	 0.047	 *	Feeling	depressed	 4.0	 4.7	 0.107	 	Sexual	desire	reduced	 0.1	 0.3	 0.012	 *	Depressive	disorder	 5.1	 6.7	 0.002	 **						 	 	 	 	
Relationship	problem	
partner	
3.5	 4.4	 0.029	 *		 	 	 	 	
Micturition	symptoms	 	 	 	 	Dysuria/painful	urination	 5.1	 5.8	 0.148	 	Urinary	frequency/urgency	 5.8	 6.9	 0.046	 *	Urination	problems	other	 2.3	 3.5	 0.001	 **	Cystitis/other	infection	 27.3	 29.6	 0.015	 *		*	p	<0.05			**	p<0.01			***p<0.001		
 






	 VVC	(n=5,088)	 Uncertain	VVC	(n=1,978)	 P-value	
Telephone	consultation	 	 	 	 	Patients	 2,898	(57.0%)	 1,643	(83.1%)	 <0.001	 ***	Consultations	per	patient	 M=1.2	(SD=1.7)	 M=3.1	(SD=4.1)	 <0.001	 ***	
	 	 	 	 	
Face-to-face	consultation	 	 	 	 	Patients	 3,524	(69.3%)	 1,801	(91.1%)	 <0.001	 ***	Consultations	per	patient	 M=1.5	(SD=2.0)	 M=3.9	(SD=4.6)	 <0.001	 ***	
	 	 	 	 	
Referrals	 	 	 	 	Patients	referred	to	gynaecology	 222	(4.4%)	 351	(17.7%)	 0.009	 **	Patients	referred	for	diagnostics	 156	(3.1%)	 241	(12.2%)	 <0.001	 ***	Patients	with	one	or	more	referrals	 1,246	(24.5%)	 995	(50.3%)	 0.006	 **	
	 	 	 	 	















Comparison with existing literature Women	with	uncertain	VVC	were	twice	more	likely	to	have	dyspareunia	and	three	times	more	likely	to	have	reduced	sexual	desire,	both	found	to	be	important	characteristics	of	PVD.10,14,20,23,25	Our	findings	that	women	with	uncertain	VVC	showed	a	significantly	higher	incidence	of	micturition	symptoms	and	of	irritable	bowel	syndrome,	are	in	line	with	findings	related	to	chronic	pelvic	pain	as	one	of	the	maintaining	factors	in	PVD.12,17,21,25	Also,	psychological	conditions	and	relationship	problems	with	a	partner,	known	to	be	associated	with	PVD,	are	more	prevalent	in	women	with	uncertain	VVC.24,29		Uncertain	VVC	was	found	to	account	for	28%	of	all	patients	diagnosed	with	VVC,	which	high	number	does	correspond	to	the	findings	of	a	Dutch	study	on	the	factors	associated	with	microbiologically	unexplained	vaginal	symptoms,	which	showed	that	25%	of	all	the	women	had	symptoms	of	unknown	aetiology.6	It	shows	the	difficulty	of	diagnosing	vulvovaginal	complaints	by	GPs,	as	was	demonstrated	previously	among	Dutch	GPs.2	This	difficulty	has	apparently	repercussions	for	the	management	of	VVC	by	GPs	as	is	seen	in	the	significantly	higher	health	care	use	in	women	with	uncertain	VVC.	While	these	findings	may	be	the	consequence	of	the	definition	of	uncertain	VVC	itself,	it	also	could	be	an	expression	of	the	well-known	association	between	MUPS	and	high	health	care	use.30	Given	the	higher	number	of	MUPS	in	the	uncertain	VVC	group,	and	the	difficulty	in	diagnosing	PVD	as	a	chronic	pain	disorder	without	clear	identifiable	cause,	the	higher	number	of	consultations	and	referrals	may	reflect	the	association	between	PVD	and	MUPS.	A	recent	study	showed	that	GPs	take	various	characteristics	like	multiple	MUPS,	frequent	and	long	consultations	and	many	referrals	into	account	when	recognizing	MUPS	in	their	patients.31	Equally,	in	case	of	uncertain	VVC,	GPs	should	be	
	50	|		
aware	that	the	increasing	number	of	consultations	and	comorbidity	of	MUPS	could	point	to	PVD.		It	is	unknown	whether	GPs	ever	consider	PVD	as	an	alternative	diagnosis.	Given	the	significantly	higher	mean	number	of	prescriptions	received	per	patient	in	the	women	with	uncertain	VVC	(twice	as	many),	GPs	seem	hold	on	to	their	initial	diagnosis	of	VVC.	This	is	in	line	with	research	that	was	conducted	among	a	group	of	Dutch	GPs,	some	years	after	the	introduction	of	the	Dutch	GPs	Guideline	on	Vaginal	Discharge,	showing	that	GPs	did	not	perform	the	examinations	required	to	confirm	their	putative	diagnosis	of	VVC,	leading	to	wrong	diagnoses	and	maltreatment	with	antimycotics.2		Our	results	also	demonstrate	that	despite	requesting	for	diagnostics	more	often	among	women	with	uncertain	VVC,	GPs	referred	more	often	to	a	gynaecologist	as	well.	This	is	in	line	with	a	study	in	patients	with	sexual	complaints	attending	Dutch	general	practitioners,	showing	that	women	with	a	sexual	dysfunction	were	more	often	referred	to	secondary	care	services	than	were	male	patients	with	a	sexual	dysfunction.32	If	PVD	were	to	be	considered	as	a	diagnosis,	a	referral	to	a	pelvic	floor	physical	therapist	or	sexologist	(or	sexual	and	relationship	therapist)	rather	than	a	gynaecologist	would	be	indicated,	as	is	stated	by	the	Dutch	GPs	Guideline	on	Sexual	complaints.33	Own	national	guidelines	might	be	consulted	in	applying	referring	policy	correctly.	Does	the	referral	policy	of	the	GPs	in	this	study	suggest	that	they	do	not	consider	any	alternative	diagnosis	when	women’s	vulvovaginal	complaints	persist?	This	hypothesis	would	be	consistent	with	studies	that	show	that	vulvodynia	is	underestimated	and	not	recognized	by	GPs.30,	34			
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Synthesis of results: population and clinic-based case-control studies All	included	population	and	clinic-based	case-control	studies	assessed	possible	PVD	risk	factors,	including	VVC	history,	using	questionnaires,	telephone	interviews,	or	chart	reviews.	Participants	were	women	with	PVD	or	healthy	controls	with	no	history	of	PVD,	recruited	from	a	random	sample	of	the	population	or	from	tertiary	health	care	centers.	Overall,	553	cases	and	668	controls	participated.	All	studies	showed	a	greater	likelihood	for	patients	diagnosed	with	PVD	to	have	a	self-reported	history	of	VVC	(ORs	2.1-6.1).			
Table	1.	Overview	of	results	of	population	based	case-control	studies	
First	author		Year	of	publication	NOS-score*	

























































Comparison with existing literature 
Significance of the pathophysiological studies for the relationship between PVD and VVC The	hypothesis	of	PVD	being	an	inflammatory	condition	has	been	adopted	58,84–86	and	rejected	87–90	several	times,	and	debate	is	still	ongoing.	It	was	shown	that	long-lasting	vulvar	hypersensitivity	could	be	induced	by	both	single	and	repeated	C.	albicans	infection	in	mice.47	Furthermore,	several	polymorphisms	in	components	of	inflammatory	pathways	have	been	shown	to	occur	more	frequently	in	PVD	patients	as	compared	to	controls,	which	may	suggest	immunologic	engagement	in	the	pathophysiology	of	PVD.25,26,28,29,91	The	findings	in	the	included	pathophysiological	studies	are	in	line	with	these	hypotheses.	Nevertheless,	it	remains	unclear	what	is	the	initial	cause	of	this	immunologic	response.	Does	the	provocative	agent	have	to	be	infectious,	or	may,	for	example,	friction	of	the	penis	during	unaroused	intercourse	in	a	non-lubricated	vagina,	lead	to	immunologic	responses	as	well?	For	example,	it	has	been	shown	that	mechanical	stretch	enhances	cytokines	production	in	different	tissues	(lung,	heart,	skin),	even	though	this	has	yet	to	be	demonstrated	in	vulvar	tissue.92,93		Furthermore,	all	included	population	studies	show	that	about	25-50%	of	the	women	with	PVD	were	found	not	to	have	a	history	of	self-diagnosed	VVC	7,37,77,78	Inversely,	nearly	75%	of	women	report	an	episode	of	self-diagnosed	VVC	at	some	point	in	their	life	while	never	developing	PVD.94	Thus,	even	if	future	studies	unequivocally	demonstrate	that	VVC	is	related	to	PVD,	it	should	not	be	considered	its	sole	causative	agent.	





Is PVD a multifactorial pain condition? In	a	systematic	review	in	2016	on	the	relationship	between	PVD	and	inflammatory	biomarkers,	the	authors	concluded	that	“there	is	limited	and	contradictory	evidence	regarding	the	characteristics	of	local	and	systemic	inflammation	in	women	with	localized,	provoked	vestibulodynia”.56	The	findings	of	our	systematic	review	also	do	not	provide	clear-cut	support	for	this	inflammation	hypothesis.	As	suggested	earlier,	perhaps	PVD	should	be	considered	as	a	(unexplained)	chronic	pain	condition.44	As	in	
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other	medically	unexplained	syndromes,	with	which	PVD	is	strongly	associated,14	women	with	PVD	are	more	likely	to	have	a	maladaptive	immune	response	and	have	been	found	to	be	more	sensitive	to	pain	at	distant	locations.101,102	Psychological	therapies	currently	applied	for	other	medically	unexplained	symptoms,	such	as	(mindfulness-based)	cognitive	behavioral	therapy,103,104	also	result	in	symptom	relief	for	PVD	patients.105–108	Apparently,	medically	unexplained	syndromes	and	PVD	share	common	causative	or	sustaining	biopsychosocial	factors.	Acceptance	of	an	integrative	model	where	PVD	is	seen	as	a	pain	condition	with	biomedical	and	psychological	associated	factors	that	do	not	dismiss	women’s	experience	of	pain	may	ultimately	be	more	beneficial	than	a	continued	sole	focus	on	medical	causes.					
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First	author	Year	of	publication	 Relevant	 Control	group	 Commentary	Babula	et	al.,	2008	 yes	 no	 Comparison	between	PVD	subjects,	no	control	group.	Dennerstein,	2008	 no	 no	 Study	describes	microscopic	examination	of	a	vaginal	smear	and	therefore	does	not	provide	an	answer	to	our	research	question.	Falsetta	et	al.,	2016	 no	 yes	 Study	looks	at	the	role	of	bradykinin	in	pain	experience	in	people	with	PVD.	The	relationship	of	bradykinin	and	Candida	vaginitis	was	not	clear	from	the	study	and	it	was	therefore	excluded.	
Giraldo	et	al.,	2012	 no	 yes	 Sexual	function	assessment	in	both	PVD	and	VVC	separately.	This	provides	no	answer	to	the	research	question.	Pagano,	2007	 no	 no	 Study	addresses	vulvodynia	in	general	and	only	addresses	the	value	of	colposcopy	in	vulvodynia	patients.	This	provides	no	answer	to	our	research	question.	
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Identifying and discussing sexual complaints  Most	GPs	were	found	to	have	difficulties	in	inquiring	about	sexual	behaviour,	unless	it	was	related	to	the	assessment	of	the	likelihood	of	a	sexually	transmitted	disease	(STD)(Box	1).	Outside	the	context	of	STDs,	GPs	were	reluctant	to	take	a	sexual	history.	In	particular	male	GPs	mentioned	hesitance	regarding	female	patients	of	their	own	age	and	mentioned	that	this	hesitancy	to	take	a	sexual	history	and	performing	a	vulvovaginal	examination	applies	more	to	themselves	than	female	GPs.	Some	male	GPs	and	no	female	GPs	were	afraid	to	be	seen	as	overly	curious,	or	felt	embarrassed	or	noticed	a	not	well-defined	feeling	of	tension	when	inquiring	about	sexual	issues.	Some	male	GPs	feared	to	be	considered	interfering	in	patients’	private	life	or	to	be	disqualified	by	the	patient,	even	when	private	or	sexual	issues	might	be	relevant	for	the	diagnosis.		A	facilitating	factor	was	the	knowledge	that	patients	could	profit	from	being	asked	about	sexual	issues.	Some	male	GPs	were	grateful	for	the	information	provided	by	their	female	colleagues	that	women	do	expect	professional	attention	to	sexual	health	issues.			



































Strengths and limitations The	strength	of	this	study	is	its	reporting	of	findings	that	were	obtained	as	a	result	of	the	interaction	between	GPs,	shown	by	the	mutual	recognition	in	identifying	sexual	complaints	and	coping	with	professional	uncertainty.	Especially	the	gender	issue	was	raised	as	a	result	of	the	interaction	between	male	and	female	GPs.	Also,	to	our	knowledge,	this	study	is	the	first	one	investigating	the	diagnostic	process	of	vulvodynia	in	general	practice.	Finally,	the	participants	in	the	focus	groups	were	heterogeneous	with	respect	to	gender,	age,	years	of	experience	and	practice	type.	Nevertheless,	self-selection	bias	of	our	participants	may	be	qualified	as	a	limitation,	as	is	seen	as	well	in	the	very	low	response	ratio	of	about	4%.	As	was	shown	in	Table	1,	a	majority	of	our	participants	had	an	active	role	in	the	education	of	GPs	and	had	a	specific	interest	in	vulvovaginal	complaints.	Perhaps,	with	GPs	with	an	average	interest	in	such	complaints,	other	themes	would	have	emerged.		
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Discussion of the most important themes Given	all	studies,	PVD	might	be	considered	in	general	practice	-	whether	or	not	concealed	by	undefined	vulvovaginal	complaints	and	other	comorbidities	-	as	one	option	in	the	differential	diagnosis	of	vulvovaginal	complaints.	However,	the	diagnostic	management	of	PVD	by	GPs	is	problematic	for	some	reasons.	Firstly	because	PVD,	due	to	its	heterogeneous,	chronic	and	multicausal	character,	may	be	seen	as	an	example	of	medically	unexplained	symptoms	(MUS),	as	will	be	addressed	in	the	next	section.	Secondly,	because	the	symptoms	of	PVD	among	other	things	arise	in	a	sexual	context	about	which	GPs	lack	knowledge	and	skills.	Thirdly,	managing	MUS	and	addressing	sexual	issues	provoke	a	feeling	of	uncertainty	in	GPs.	Therefore,	the	following	three	themes	are	considered	and	will	be	discussed	further:	the	management	of	medically	unexplained	symptoms	(MUS);	addressing	sexual	health	in	general	practice;	and	coping	with	professional	uncertainty.			
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The management of medically unexplained symptoms  Firstly,	the	question	of	whether	PVD	fits	in	the	illness	script	of	MUS	will	be	addressed,	as	this	might	support	the	GP	in	the	management	of	PVD.	Afterwards	some	remarks	will	be	made	about	how,	based	on	the	concept	of	MUS,	a	biopsychosocial	approach	in	general	practice	can	be	used	to	improve	the	management	of	PVD.	
	











Addressing sexual health in general practice In	this	section	I	will	make	clear	how	sexual	health	is	addressed	in	general	practice,	and	provide	some	arguments	of	why	improvements	are	necessary.	Thereafter,	I	will	focus	on	the	barriers	GPs	experience	in	talking	about	sex	and	the	unmet	needs	of	their	patients.			
	
Is underreporting of sexual complaints in general practice problematic? Arguments for GPs to 







Talking about sex Talking	about	sex	between	the	GP	and	women	with	PVD	shows	to	be	an	important	topic	in	the	two	qualitative	studies	we	carried	out.4,5	The	participating	GPs	experienced	reluctance	in	bringing	this	subject	forward.	In	particular	male	GPs,	more	than	female	GPs,	mentioned	reluctance	in	taking	a	sexual	history	in	female	patients	of	their	own	age	and	performing	a	vulvovaginal	examination.	Male	GPs	were	also	afraid	to	be	perceived	as	overly	curious,	felt	embarrassed	or	noticed	a	not	well-articulated	feeling	of	tension	when	inquiring	about	sexual	issues.	GPs	feared	to	be	considered	interfering	in	patients’	private	life	or	to	be	disqualified	by	the	patient,	even	when	private	or	sexual	issues	might	be	relevant	for	the	diagnosis.4	A	facilitating	factor	was	the	knowledge	that	patients	could	benefit	from	being	asked	about	sexual	issues	and	this	was	confirmed	by	our	qualitative	study	among	women	with	PVD.5	The	reasons	why	GPs	don't	talk	about	sex	have	been	known	for	some	time.	The	most	important	themes	are	fear	about	"opening	up	a	can	of	worms",	lack	of	time,	resources	and	training,	concern	about	knowledge	and	abilities,	worry	about	causing	offense,	personal	discomfort,	and	a	lack	of	awareness	about	sexual	issues.55–58	In	addition,	GPs	sometimes	experienced	personal	discomfort	in	discussing	sexual	issues	with	patients	of	the	opposite	sex,	with	black	and	ethnic	minority	groups,	older	and	non-heterosexual	service	users,	and	people	with	intellectual	disabilities.55–58	It	is	not	only	GPs	who	feel	reluctance	in	discussing	sexual	issues.	Doctors	and	nurses	who	have	limited	knowledge	about	sexual	complications	and	those	who	feel	uncomfortable	discussing	sexual	issues	are	all	less	likely	to	discuss	these	matters	with	patients,	using	embarrassment	patients	may	experience	as	the	main	excuse.59	Moreover,	GPs	show	similar	reactions	when	they	are	confronted	with	anal	complaints.60	Apparently,	taboo	subjects	in	general	cause	discomfort	and	reluctance	among	physicians	and	this	is	not	limited	to	sexuality	and	general	practice.			Contrary	to	the	findings	among	GPs,	talking	about	sexuality	was	not	experienced	as	a	barrier	by	the	women	with	PVD	in	our	study,	neither	was	the	gender	of	the	GP	they	talked	with	about	sexuality,	provided	that	the	GP	showed	patient-centred	care:	genuine	involvement,	empathy	and	making	shared	decisions.	Participants	expected	the	GP	to	
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initiate	talking	about	sexuality	regarding	their	complaints.	The	women	in	our	study	understood	that	it	was	needed	to	address	sexuality	even	when	their	partner	was	invited	to	the	GP,	which	was	seldom	done.	This	relatively	positive	and	cooperative	attitude	of	women	towards	sexual	history	taking	was	consistently	shown	in	many	other	studies,	in	varying	situations	such	as	for	example	sexual	assault,	chronic	disease,	cancer,	STI	and	general	medical	problems,	and	in	both	primary	care	and	outpatient	departments.61–72	Unfortunately,	most	studies	around	this	topic	had	a	qualitative	design	and	were	not	conducted	in	representative	samples.	For	the	time	being,	there	are	no	studies	that	allow	for	an	opposite	conclusion.	These	contrasting	findings	between	the	apparently	relatively	open	attitude	of	the	patients	and	the	reluctance	of	GPs	are	challenging.	What	is	the	meaning	of	these	findings?	Are	GPs	hiding	behind	an	excuse	when	they	explain	their	reluctance	by	directing	blame	to	patients?	Could	it	be	an	expression	of	a	specific	or	a	general	uncertainty?			
Coping with professional uncertainty First	of	all	I	will	describe	how	uncertainty	experienced	by	the	GP	during	the	diagnostic	process	is	shaped	by	the	consultation	itself.	The	context	of	the	doctor-patient	relationship	regarding	the	management	of	diagnostic	uncertainty	may	be	more	important	than	the	fear	of	negative	medical	outcomes	or	the	use	of	guidelines	in	medical	reasoning.	Secondly,	I	will	describe	the	importance	of	a	patient-centred	approach	for	the	management	of	uncertainty.	Thirdly,	it	will	be	discussed	whether	expressing	professional	uncertainty	to	patients	would	be	beneficial	to	them.	Afterwards,	uncertainty	of	the	GP	will	be	discussed	in	the	light	of	competencies	and	finally,	professional	uncertainty	and	false	safety	behaviour	will	be	considered.		





A patient-centred approach and the management of uncertainty A	patient-centred	approach	including	shared	decision	making	is	vital	for	the	management	of	professional	uncertainty.73,75,76	This	mechanism	was	also	demonstrated	in	our	qualitative	study	among	women	with	PVD	who	valued	GPs	disclosing	of	uncertainty	positively,	provided	that	the	woman	felt	that	the	GP	also	showed	empathy	and	took	her	seriously.5	Moreover,	it	was	shown	in	an	implementation	study	of	shared	decision	making	that	primary	care	physicians	who	cope	well	with	their	professional	uncertainty	may	be	more	likely	to	support	shared	decision	making.77	A	qualitative	study	among	supervisors	and	registrars	in	general	practice	demonstrated	that	when	GPs	lack	a	framework	for	managing	patients	with	MUS,	this	might	lead	to	negative	feelings	such	as	helplessness,	frustration	and	shame	towards	patients,	which	feelings	were	experienced	as	uncomfortable	and	confronting.78	GPs’	stress	reactions	to	experienced	uncertainty	were	shown	to	be	associated	with	having	a	biomedical	attitude,	whereas	low	stress	to	experienced	uncertainty	was	associated	with	having	a	biopsychosocial	attitude.79	These	
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findings	demonstrate	that	GPs	who	assume	a	biopsychosocial	approach	may	feel	more	comfortable	during	consultations.			
Expression of professional uncertainty GPs	verbal	expressions	of	professional	uncertainty	in	a	consultation,	be	it	diagnostic	uncertainty	(“I'm	not	sure	what	might	cause	your	complaints”)	or	therapeutic	uncertainty	(“I’m	not	sure	whether	this	is	the	right	treatment,	but	please	come	back	when	it	doesn’t	work.”),	might	be	seen	as	a	way	to	cope	with	these	hesitations,	because	clear	communication	of	uncertainty	may	prevent	unrealistic	patient	expectations	(“The	doctor	knows	best”).	However,	expression	of	uncertainty	to	patients	was	not	necessarily	beneficial,	as	the	impact	of	expressions	of	uncertainty	upon	patients’	confidence	showed	not	to	be	consistent.80	A	study	that	investigated	the	impact	on	patients	of	fourteen	scenario’s	that	exemplified	verbal	or	behavioural	expressions	of	GP	uncertainty	showed,	however,	that	verbal	expressions	(such	as	‘I	don’t	know’,	or	‘Let’s	see	what	happens’)	resulted	in	patients	trusting	GPs	less,	whereas	behavioural	expressions	of	uncertainty	(such	as	asking	the	advice	of	a	medical	specialist,	referring	the	patient	to	a	hospital,	or	using	a	book	or	computer	during	the	consultation),	resulted	in	patients	trusting	GPs	more.80	Not	only	was	there	a	difference	in	trustworthiness	between	verbal	and	behavioural	expressions	of	uncertainty,	the	effects	of	such	expressions	of	uncertainty	on	patients	also	seemed	to	depend	on	gender	of	the	GP.	In	one	study	it	was	found	that	expressed	uncertainty	was	negatively	related	to	patient	satisfaction	only	when	the	physician	was	a	woman	and	the	patient	was	a	man.81			





Professional uncertainty and false safety behaviour  Sometimes	uncertainty	can	be	dealt	with	by	false	safety	behaviour.	Regarding	recurrent	vulvovaginal	PVD-like	symptoms,	a	GP	and	the	woman	might	be	satisfied	on	the	short-term	by	a	‘conspiracy	of	somatisation’.	This	means	that	both	GPs	and	women	seem	to	hide	behind	a	false	certainty	of	a	somatic	disorder,	so	as	to	be	able	to	avoid,	for	example,	discussion	of	the	sexual	or	relational	context	of	a	particular	problem.	Possibly,	GPs’	lack	of	competence	to	diagnose	and	treat	PVD	and	their	reluctance	to	discuss	sexual	issues,	maintains	the	negative	beliefs	and	experiences	of	women	regarding	the	benefit	of	seeking	help.	Given	the	social	context	of	the	coital	imperative	and	the	presumed	quick	fix	medical	solution	in	which	women	seek	to	be	‘normal’	and	to	be	taken	seriously,	most	women	with	PVD	searching	for	legitimacy	of	their	problem	ultimately	experience	frustration,	failure	and	shame.18,19,85–88	GPs	and	women	with	PVD	might	be	entangled	in	a	mind-body	struggle	in	which	doctors’	sincere	but	ineffective	somatic	efforts	maintain	women’s	avoidance	of	facing	her	complaints	as	a	sexual	and	a	chronic	pain	problem,	which	asks	for	another	diagnostic	and	therapeutic	perspective	rather	than	just	a	medical	one.	As	this	perspective	may	elicit	some	uncertainty	for	both	GP	and	a	woman,	they	erroneously	turn	to	a	merely	somatic	approach.	
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